Suppr超能文献

功能性核糖体生物发生是 p53 不稳定的前提条件:化疗对核仁功能和 RNA 代谢的影响。

Functional ribosome biogenesis is a prerequisite for p53 destabilization: impact of chemotherapy on nucleolar functions and RNA metabolism.

机构信息

Department of Molecular Epigenetics, Helmholtz Zentrum München and Center for Integrated Protein Science Munich, Marchioninistrasse 25, 81377 Munich, Germany.

出版信息

Biol Chem. 2013 Sep;394(9):1133-43. doi: 10.1515/hsz-2013-0153.

Abstract

The production and processing of ribosomal RNA is a complex and well-coordinated nucleolar process for ribosome biogenesis. Progress in understanding nucleolar structure and function has lead to the unexpected discovery of the nucleolus as a highly sensitive sensor of cellular stress and an important regulator of the tumor suppressor p53. Inhibition of ribosomal RNA metabolism has been shown to activate a signaling pathway for p53 induction. This review elucidates the potential of classical and recently developed chemotherapeutic drugs to stabilize p53 by inhibiting nucleolar functions.

摘要

核糖体 RNA 的产生和加工是核糖体生物发生中一个复杂而协调良好的核仁过程。对核仁结构和功能的认识进展导致了一个意想不到的发现,即核仁是细胞应激的高度敏感传感器,也是肿瘤抑制因子 p53 的重要调节剂。抑制核糖体 RNA 代谢已被证明能激活 p53 诱导的信号通路。这篇综述阐明了经典和最近开发的化疗药物通过抑制核仁功能稳定 p53 的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验